Enanta Pharmaceuticals, Inc. (ENTA)
14.64
+0.46
(+3.24%)
USD |
NASDAQ |
Dec 09, 16:00
14.62
-0.02
(-0.14%)
Pre-Market: 20:00
Enanta Pharmaceuticals Profit Margin (Quarterly): -123.6% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -255.9% |
| Palatin Technologies, Inc. | 52.87% |
| Theriva Biologics, Inc. | -- |
| Oragenics, Inc. | -- |
| NanoViricides, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -85.63% |
| Return on Assets | -24.72% |
| Return on Invested Capital | -26.42% |
| Gross Profit Margin (Quarterly) | 91.51% |
| Operating Margin (Quarterly) | -121.6% |
| Return on Net Operating Assets | -99.56% |